Diagnostics (Sep 2023)

Membranous Expression of Heart Development Protein with EGF-like Domain 1 Is Associated with a Good Prognosis in Patients with Bladder Cancer

  • Kohei Mori,
  • Kazumasa Matsumoto,
  • Masaomi Ikeda,
  • Dai Koguchi,
  • Yuriko Shimizu,
  • Hideyasu Tsumura,
  • Daisuke Ishii,
  • Shoutaro Tsuji,
  • Yuichi Sato,
  • Masatsugu Iwamura

DOI
https://doi.org/10.3390/diagnostics13193067
Journal volume & issue
Vol. 13, no. 19
p. 3067

Abstract

Read online

Objective: To investigate the correlation between total protein expression of heart development protein with EGF-like domain 1 (HEG1) and clinicopathological characteristics in patients with bladder cancer (BC) after radical cystectomy (RC). Patients and Methods: We retrospectively analyzed data from 110 patients who underwent RC at Kitasato University Hospital. And we prepared an anti-HEG1 monoclonal antibody W10B9, which can detect total HEG1 protein. HEG1 protein expression in tumor cells was evaluated separately for membrane and cytoplasmic staining using immunohistochemistry. Results: Membranous HEG1 expression was associated with absent lymphovascular invasion (p p p p = 0.01). Expression of membranous HEG1 was identified as an independent prognostic factor for RFS (p = 0.04). There were no significant differences between cytoplasmic HEG1 expression and clinicopathologic factors including prognosis. Conclusion: The expression of membranous HEG1 could serve as a favorable prognostic indicator in patients with BC treated with RC.

Keywords